Structure Info
- Chemspace ID
- CSSS00009815905 (In-Stock Screening Compounds)
- CAS
- 319-78-8
- MFCD
- MFCD00064221, MFCD00066445, MFCD00064221
- IUPAC Name
- (2R,3R)-2-amino-3-methylpentanoic acid
- Mol formula
- C6H13NO2
- Mol weight
- 131 Da
- Catalog Number(s)
- 319-78-8, 3252, 325325, 819422, A306435, A471003815, AA00I5YY, ACDS-063117, AD06590, AG00I61Q, AG329026, AI47446, AQ47446, AR00I6QQ, ArZ-UP114288, ArZ-UP199609, ArZ-UP341719, ArZ-UP347245, BAT-003494, BB4LS-EN300-101180, BBV-38372629, BD9690, CD21008681, CM252172, CP01204, CS-0011143, CSC009815905, D278321, D66244, D912019, DS-18182, E726, EN300-101180, FD21838, FD21838-0.25G, FI09261, HY-I1070, I0179, I820210, JH671175, LAN-B84179, LN00008702, M03125, M24252, NA-0075, O28696, OR36341, PB1203655491, RS20001525, SC-09609, SY022277, T9143, Y1049991, Z1203578023, ZX-AE053989, ZX-NM242884
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- -1.51
- Heavy atoms count
- 9
- Rotatable bond count
- 3
- Number of rings
- 0
- Carbon bond saturation, Fsp3
- 0.833
- Polar surface area (Å)
- 63
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 2
- Zoom the structure
- CSSS00009815905
Items Overall 16 items from 3 suppliers
Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
---|---|---|---|---|---|---|
Enamine Ltd | 5 days | Ukraine To: | 90 | 1 mg | 104 | |
Enamine Ltd | 5 days | Ukraine To: | 90 | 2 mg | 108 | |
Enamine Ltd | 5 days | Ukraine To: | 90 | 5 mg | 118 | |
Enamine Ltd | 5 days | Ukraine To: | 90 | 10 mg | 135 | |
Enamine Ltd | 5 days | Ukraine To: | 90 | 20 mg | 169 | |
MedChemExpress | 10 days | United States To: | 98 | 25 mg | 40 | |
MedChemExpress | 10 days | United States To: | 98 | 50 mg | 65 | |
MedChemExpress | 10 days | United States To: | 98 | 100 mg | 100 | |
MedChemExpress | 10 days | United States To: | 98 | 10mM/1mL | 44 | |
Description: Names: D-Isoleucine; (R)-Isoleucine; Product Description: D-Isoleucine ((R)-Isoleucine), an isoleucine stereoisomer, is a selective activator of Asc-1 antiporter, which enhances long-term potentiation at the hippocampal CA1-CA3 via release of endogenous D-serine .; Target: ASCT; CAS: 319-78-8 | ||||||
MedChemExpress EU | 10 days | Sweden To: | 99 | 25 mg | 42 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 50 mg | 68 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 100 mg | 105 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 250 mg | 168 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 1 g | 316 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 5 g | 790 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 10mM/1mL | 46 | |
Description: Names: D-Isoleucine; (R)-Isoleucine; Product Description: D-Isoleucine is a selective competitive activator of the Asc-1 antiporter (Ki=0.98 mM). D-Isoleucine promotes the release of D-serine and glycine by binding to the Asc-1 protein on the neuronal cell membrane, and enhances NMDA receptor-dependent synaptic plasticity. D-Isoleucine can be used in the study of neurodegenerative diseases (such as Alzheimer's disease and schizophrenia). D-Isoleucine also acts as a non-classical D-amino acid, interferes with bacterial peptidoglycan synthesis, and inhibits the formation of Staphylococcus aureus biofilm, and has potential antibacterial application value; Target: ASCT; CAS: 319-78-8 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire